CIBC Private Wealth Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$230K Hold
2,200
﹤0.01% 1131
2025
Q3
$203K Hold
2,200
﹤0.01% 1173
2025
Q2
$176K Hold
2,200
﹤0.01% 1173
2025
Q1
$166K Hold
2,200
﹤0.01% 1150
2024
Q4
$184K Hold
2,200
﹤0.01% 1187
2024
Q3
$191K Sell
2,200
-40
-2% -$3.42K ﹤0.01% 1210
2024
Q2
$181K Hold
2,240
﹤0.01% 1143
2024
Q1
$178K Buy
+2,240
New +$174K ﹤0.01% 1173
2019
Q3
Sell
-25,970
Closed -$1.56M 927
2019
Q2
$1.56M Sell
25,970
-16,000
-38% -$982K 0.01% 507
2019
Q1
$2.73M Sell
41,970
-5,430
-11% -$357K 0.01% 414
2018
Q4
$2.96M Sell
47,400
-1,700
-3% -$115K 0.01% 394
2018
Q3
$3.61M Sell
49,100
-2,100
-4% -$151K 0.01% 407
2018
Q2
$3.44M Hold
51,200
0.01% 410
2018
Q1
$3.19M Hold
51,200
0.01% 424
2017
Q4
$3.29M Hold
51,200
0.01% 412
2017
Q3
$3.35M Sell
51,200
-1
-0% -$63 0.02% 394
2017
Q2
$3.21M Buy
51,201
+24,501
+92% +$1.47M 0.02% 328
2017
Q1
$1.57M Buy
+26,700
New +$1.56M 0.01% 402

Other funds holding PJP

CIBC Private Wealth Group's PJP Position: Q4 2025 in Review

CIBC Private Wealth Group held its Invesco Pharmaceuticals ETF (PJP) position steady in Q4 2025 at 2,200 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #1131.

CIBC Private Wealth Group first reported a position in PJP in Q1 2017 and has held it in 18 quarters since. The position peaked at $3.61M in Q3 2018. 105 funds tracked by Wall St. Rank hold PJP as of Q4 2025.

  • CIBC Private Wealth Group held 2,200 shares of Invesco Pharmaceuticals ETF worth $230K as of Q4 2025.
  • CIBC Private Wealth Group left its Invesco Pharmaceuticals ETF share count unchanged in Q4 2025.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1131 holding.
  • CIBC Private Wealth Group first reported a position in Invesco Pharmaceuticals ETF in Q1 2017 and has held it in 18 quarters since.
  • CIBC Private Wealth Group's Invesco Pharmaceuticals ETF position peaked at $3.61M in Q3 2018.
  • 105 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.